Aliskiren, the first approved renin inhibitor: Clinical application and safety in the treatment of hypertension

By Riccioni Graziano  

Advances in Therapy, Vol. 26, Iss. 7, 2009-07 ,pp. : 700-710

Springer Publishing Company

Access to resources Recommend Favorite

A study of the pharmacokinetic interactions of the direct renin inhibitor aliskiren with metformin, pioglitazone and fenofibrate in healthy subjects

By Vaidyanathan Sujata   Maboudian Mojdeh   Warren Vance   Yeh Ching-Ming   Dieterich Hans Armin   Howard Dan   Dole William P.  

Current Medical Research and Opinion, Vol. 24, Iss. 8, 2008-08 ,pp. : 2313-2326

Informa Healthcare

Access to resources Recommend Favorite

Effect of aliskiren, an oral direct renin inhibitor, on the pharmacokinetics and pharmacodynamics of a single dose of acenocoumarol in healthy volunteers

By Huang H.-L. A.   Vaidyanathan S.   Yeh C.-M.   Bizot M.-N.   Dieterich H. A.   Dole W. P.   Howard D.  

Current Medical Research and Opinion, Vol. 24, Iss. 9, 2008-09 ,pp. : 2449-2456

Informa Healthcare

Access to resources Recommend Favorite

Long-term safety, tolerability and efficacy of combination therapy with aliskiren and amlodipine in patients with hypertension

By Littlejohn Thomas W.   Trenkwalder Peter   Hollanders Geert   Zhao Yanxing   Liao Weichi  

Current Medical Research and Opinion, Vol. 25, Iss. 4, 2009-04 ,pp. : 951-959

Informa Healthcare

Access to resources Recommend Favorite

Long-term safety, tolerability and efficacy of aliskiren in combination with valsartan in patients with hypertension: a 6-month interim analysis

By Chrysant Steven G.   Murray Alexander V.   Hoppe Uta C.   Dattani Dan   Patel Samir   Hsu Huang   Zhang Jack  

Current Medical Research and Opinion, Vol. 24, Iss. 4, 2008-04 ,pp. : 1039-1047

Informa Healthcare

Access to resources Recommend Favorite